Biggest News Aggregation in the World
📰 Analytical Tool News

Page 2 - Analytical Tool News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Analytical Tool. Real-time updates on events, politics, business and more.

Cancer Vaccines Analytical Tool 2022: Coverage of 372 Companies Plus Partners Developing 767 Cancer Vaccine Drugs with 482 in Active Development Across 211 Different Targets

/PRNewswire/ -- The "Cancer Vaccines: Analytical Tool" report has been added to ResearchAndMarkets.coms offering. Cancer Vaccines: Analytical Tool is the must...
Laura Wood E St Office Hours Call Office Hours Call Clinical Trial Development Biomarker Companion Diagnostic Development Business Development Licensing

Cancer Vaccines Analytical Tool 2022: Coverage of 372 Companies Plus Partners Developing 767 Cancer Vaccine Drugs with 482 in Active Development Across 211 Different Targets

/PRNewswire/ -- The "Cancer Vaccines: Analytical Tool" report has been added to ResearchAndMarkets.coms offering. Cancer Vaccines: Analytical Tool is the must...
Laura Wood E St Office Hours Call Office Hours Call Clinical Trial Development Biomarker Companion Diagnostic Development Business Development Licensing

2022 Protein Kinase Inhibitors in Oncology Analytical Tool: Coverage of 508 Companies Plus Partners who are Developing 1668 PKI Drugs with 940 in Active Development in Across 322 Different Targets

/PRNewswire/ -- The "Protein Kinase Inhibitors in Oncology: Analytical Tool" report has been added to ResearchAndMarkets.coms offering. Protein Kinase...
Laura Wood E St Office Hours Call Office Hours Call Clinical Trial Development Biomarker Companion Diagnostic Development Business Development Licensing

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

2022 Protein Kinase Inhibitors in Oncology Analytical Tool: Coverage of 508 Companies Plus Partners who are Developing 1668 PKI Drugs with 940 in Active Development in Across 322 Different Targets

/PRNewswire/ -- The "Protein Kinase Inhibitors in Oncology: Analytical Tool" report has been added to ResearchAndMarkets.coms offering. Protein Kinase...
Laura Wood E St Office Hours Call Office Hours Call Clinical Trial Development Biomarker Companion Diagnostic Development Business Development Licensing

Targeting the CD47-SIRPA Axis in Oncology Analytical Tool 2022: 70 Companies and Partners Developing 81 CD47-SIRPA Axis Targeting Drugs 76 in Active Development Across 28 Different Targets

/PRNewswire/ -- The "Targeting the CD47-SIRPA Axis in Oncology: Analytical Tool" report has been added to ResearchAndMarkets.coms offering. Targeting the...
Laura Wood E St Office Hours Call Office Hours Call Clinical Trial Development Biomarker Companion Diagnostic Development Business Development Licensing

World Immune-checkpoint Drugs in Oncology Analysis 2022: Unparalleled Biomarker Surveillance & Access to Key Developments at the World-Leading Cancer Meetings

/PRNewswire/ -- The "Immune-checkpoint Drugs in Oncology: Analytical Tool" report has been added to ResearchAndMarkets.coms offering. Immune-checkpoint Drugs...
Laura Wood E St Office Hours Call Office Hours Call Clinical Trial Development Biomarker Companion Diagnostic Development Business Development Licensing

2022 Bispecific CD3 Molecules in Oncology Analytical Tool: Must have Handbook for Any Business Developer, BI/CI Operative or Clinical Developer

/PRNewswire/ -- The "Bispecific CD3 Molecules in Oncology: Analytical Tool" report has been added to ResearchAndMarkets.coms offering. There is a considerable...
Laura Wood E St Office Hours Call Office Hours Call Clinical Trial Development Biomarker Companion Diagnostic Development Business Development Licensing

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science